SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008859
Filing Date
2022-05-16
Accepted
2022-05-16 07:30:56
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pasg-20220331x10q.htm   iXBRL 10-Q 1688784
2 EX-31.1 pasg-20220331xex31d1.htm EX-31.1 15801
3 EX-31.2 pasg-20220331xex31d2.htm EX-31.2 15457
4 EX-32.1 pasg-20220331xex32d1.htm EX-32.1 6521
5 EX-32.2 pasg-20220331xex32d2.htm EX-32.2 6371
6 GRAPHIC pasg-20220331x10q001.jpg GRAPHIC 87698
  Complete submission text file 0001558370-22-008859.txt   6582625

Data Files

Seq Description Document Type Size
7 EX-101.SCH pasg-20220331.xsd EX-101.SCH 42785
8 EX-101.CAL pasg-20220331_cal.xml EX-101.CAL 43358
9 EX-101.DEF pasg-20220331_def.xml EX-101.DEF 136681
10 EX-101.LAB pasg-20220331_lab.xml EX-101.LAB 399245
11 EX-101.PRE pasg-20220331_pre.xml EX-101.PRE 278720
53 EXTRACTED XBRL INSTANCE DOCUMENT pasg-20220331x10q_htm.xml XML 1104803
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39231 | Film No.: 22925466
SIC: 2836 Biological Products, (No Diagnostic Substances)